What’s Propelling Critical Outcome Technologies Inc. to Increase So Much?

 What's Propelling Critical Outcome Technologies Inc. to Increase So Much?

The stock of Critical Outcome Technologies Inc. (CVE:COT) is a huge mover today! About 136,800 shares traded hands or 61.65% up from the average. Critical Outcome Technologies Inc. (CVE:COT) has risen 6.00% since November 1, 2016 and is uptrending. It has outperformed by 0.07% the S&P500.
The move comes after 6 months positive chart setup for the $59.26M company. It was reported on Dec, 1 by Barchart.com. We have $0.48 PT which if reached, will make CVE:COT worth $2.96M more.

More notable recent Critical Outcome Technologies Inc. (CVE:COT) news were published by: Medgadget.com which released: “Therapeutics under development by Critical Outcome Technologies Inc.Product …” on November 30, 2016, also Medgadget.com with their article: “Critical Outcome Technologies Inc. – Product Pipeline Review – 2016” published on November 26, 2016, Business.Financialpost.com published: “Podcast: Critical Outcome Technologies CEO Wayne Danter on new ways to develop …” on May 31, 2016. More interesting news about Critical Outcome Technologies Inc. (CVE:COT) were released by: Marketwired.com and their article: “Critical Outcome Technologies Announces Next Clinical Candidate, COTI-219 …” published on October 11, 2016 as well as Marketwired.com‘s news article titled: “Critical Outcome Technologies Reports Year-End Financial & Operating Results” with publication date: August 03, 2016.

Critical Outcome Technologies Inc. is a clinical-stage biopharmaceutical company. The company has a market cap of $59.26 million. The Firm is engaged in drug discovery and development. It currently has negative earnings. The Firm uses machine learning to develop targeted therapies thereby managing the timeline and cost of getting new drug therapies to market.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment